New strategies are needed to address the current and future shortages of radioisotopes that threaten medical research and treatment.
The Scientist
Most Recent
Studying the earliest events in visual development, Carla Shatz has learned the importance of looking at one’s data with open eyes—and an open mind.
This animation illustrates optogenetics—a radical new technology for controlling brain activity with light. Ed Boyden, the co-inventor of this technology, is a professor at the MIT Media Lab and at the McGovern Institute for Brain Research, where he continues to develop new technologies for controlling brain activity.
When European explorers and fishermen began to frequent Canada’s shores in the 16th century, they brought with them a plethora of tools and trinkets, including knives, axes, kettles, and blankets. The region’s indigenous people traded the Europeans f
United Nation officials declare rinderpest the first animal disease to be fully eradicated.
Despite drug company’s and patients’ pleading, an FDA panel votes to rescind Avastin approval for breast cancer.
A male hormone-blocker currently used to treat prostate cancer may also benefit breast cancer patients.
A new report suggests that potential malaria treatments currently under study comprise the largest drug pipeline in history.
Revising a dysfunctional gene in vivo for the first time, researchers successfully restore blood clotting in hemophiliac mice.
The virulent stain that has killed 48 people produces Shiga toxin and sticks to the intestinal wall.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
